Seeing Is Believing
Currently out of the existing stock ratings of Swayampakula Ramakanth, 477 are a BUY (95.98%), 19 are a HOLD (3.82%), 1 are a SELL (0.2%).
Analyst Swayampakula Ramakanth, carries an average stock price target met ratio of 33.77% that have a potential upside of 51.21% achieved within 186 days. Previously, Swayampakula Ramakanth worked at HC WAINWRIGHT.
Swayampakula Ramakanth’s has documented 905 price targets and ratings displayed on 63 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CLGN, Collplant Biotechnologies Ltd at 21-Aug-2025.
Analyst best performing recommendations are on EKSO (EKSO BIONICS HOLDINGS).
The best stock recommendation documented was for EKSO (EKSO BIONICS HOLDINGS) at 5/6/2025. The price target of $4 was fulfilled within 27 days with a profit of $3.57 (830.23%) receiving and performance score of 307.49.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$4
$-0.04 (-0.99%)
$9
4 months 2 days ago
(06-May-2025)
2/9 (22.22%)
$3.57 (830.23%)
349
Which stock is Swayampakula Ramakanth is most bullish on?
Which stock is Swayampakula Ramakanth is most reserved on?
What Year was the first public recommendation made by Swayampakula Ramakanth?